| Literature DB >> 34528518 |
Jie Yu1, Xin-Hui Jiang2, Lian-Fang Du1, Min Bai1, Zhao-Jun Li1, Qiu-Sheng Shi1, Qi Jiang3, Fan Li1.
Abstract
Contrast-enhanced ultrasound (CEUS) is a new form of ultrasound (US) that can dynamically display microvessels in a highly sensitive manner. The purpose of this study was to investigate the efficacy of CEUS for characterizing testicular lesions in comparison with conventional US. Forty-seven patients with testicular lesions were enrolled. The histopathology results revealed that 31 cases were neoplastic (11 cases of seminomas, 8 nonseminomatous germ cell tumors, 8 lymphomas, 2 Leydig cell tumors, and 2 nonspecific tumors), and 16 cases were nonneoplastic (8 cases of infarctions, 3 epidermoid cysts, and 5 inflammation). The indicators of shallow lobulated morphology and cystic-solid echogenicity on conventional US were suggestive of germ cell tumors. More indicators on CEUS were found to be useful for characterizing testicular lesions. All the neoplastic lesions showed hyperenhancement on CEUS. Moreover, germ cell tumors presented with heterogeneous enhancement (73.7%, 14/19), a twisted blood vessel pattern, rapid wash-in and wash-out, and peripheral rim hyperenhancement signs. Lymphoma was characterized by nonbranching linear vessel patterns (87.5%, 7/8), rapid wash-in and slow wash-out. In nonneoplastic lesions, infarction and epidermoid cysts showed no enhancement, and abscesses were observed with marginal irregular enhancement. The sensitivity, specificity, and accuracy of CEUS for differentiating between neoplastic and nonneoplastic lesions were 100%, 93.8%, and 97.9%, respectively, and these values were higher than those for conventional US (90.3%, 62.5%, and 80.9%, respectively). CEUS can sensitively reflect the microvascular perfusion in testicular lesions and offers high accuracy for characterizing them.Entities:
Keywords: characterization; contrast-enhanced ultrasound; diagnosis; testicular neoplasms; ultrasound
Mesh:
Substances:
Year: 2022 PMID: 34528518 PMCID: PMC8887098 DOI: 10.4103/aja202158
Source DB: PubMed Journal: Asian J Androl ISSN: 1008-682X Impact factor: 3.285
Clinical characteristics of 47 patients with testicular lesions
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
| |||||
|
|
|
|
|
| ||
| Neo ( | ||||||
| Seminoma ( | 39 | 7 | 2 | 2 | 8 | 3 |
| NSGCT ( | 33 | 5 | 2 | 1 | 7 | 1 |
| Lymphoma ( | 66 | 5 | 2 | 1 | 6 | 2 |
| Leydig cell tumor ( | 57 | 2 | 0 | 0 | 1 | 1 |
| Nonspecific tumor ( | 26 | 2 | 0 | 0 | 2 | 0 |
| Nonneo ( | ||||||
| Infarction ( | 22 | 1 | 7 | 0 | 6 | 2 |
| Epidermoid cyst ( | 24 | 3 | 0 | 0 | 2 | 1 |
| Inflammation ( | 72 | 1 | 4 | 0 | 3 | 2 |
| 0.834 | 0.003 | 0.770 | ||||
NSGCT: nonseminomatous germ cell tumor; Neo: neoplasms; Nonneo: nonneoplasms
Characteristics of testicular lesions on conventional ultrasound (n=47)
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Neo ( | |||||
| Seminoma ( | 8/3 | 47.0±20.9 | 9/2 | 6/5/0 | 6/5 |
| NSGCT ( | 8/0 | 56.4±22.4 | 5/3 | 0/3/5 | 1/7 |
| Lymphoma ( | 7/1 | 46.2±19.4 | 0/8 | 8/0/0 | 8/0 |
| Leydig cell tumor ( | 2/0 | 7.5±3.5 | 0/2 | 2/0/0 | 1/1 |
| Nonspecific tumor ( | 1/1 | 35.5±0.7 | 0/2 | 1/1/0 | 1/1 |
| Nonneo ( | |||||
| Infarction ( | 8/0 | 35.8±17.0 | 0/8 | 0/7/1 | 0/8 |
| Epidermoid cyst ( | 3/0 | 21.7±3.8 | 0/3 | 0/3/0 | 0/3 |
| Inflammation ( | 4/1 | 32.6±11.2 | 1/4 | 1/4/0 | 5/0 |
| | 0.617 | 0.028 | 0.017 | <0.001 | 0.125 |
NSGCT: nonseminomatous germ cell tumor; homo: homogeneous; hetero: heterogeneous; hypo: hypovascularization; hyper: hypervascularization; neo: neoplasms; nonneo: nonneoplasms; CDFI: color Doppler flow imaging; s.d.: standard deviation
Characteristics of testicular lesions on contrast-enhanced ultrasound (n=47)
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Neo ( | |||||
| Seminoma ( | 11/0/0 | 5/6 | 11/0 | 10/1/0/0 | 11/0 |
| NSGCT ( | 8/0/0 | 0/8 | 8/0 | 8/0/0/0 | 8/0 |
| Lymphoma ( | 8/0/0 | 8/0 | 0/8 | 1/7/0/0 | 1/7 |
| Leydig cell tumor ( | 2/0/0 | 2/0 | 0/2 | 0/0/2/0 | 0/2 |
| Nonspecific tumor ( | 2/0/0 | 2/0 | 2/0 | 0/0/2/0 | 2/0 |
| Nonneo ( | |||||
| Infarction ( | 0/0/8 | NA | NA | NA | NA |
| Epidermoid cyst ( | 0/0/3 | NA | NA | NA | NA |
| Inflammation ( | 5/0/0 | 1/4 | 0/5 | 0/0/1/4 | 0/5 |
| | <0.001 | 0.335 | 0.008 | <0.001 | 0.005 |
NSGCT: nonseminomatous germ cell tumor; hyper: hyperenhancement; hypo: hypoenhancement; hetero: heterogeneous; homo: homogeneous; neo: neoplasms; nonneo: nonneoplasms; NA: not applicable; CEUS: contrast-enhanced ultrasound
Reviewing results of conventional ultrasound between Observer I and Observer II
|
|
| |||||
|---|---|---|---|---|---|---|
|
| ||||||
|
|
|
|
|
|
| |
| 1 | 2 (4.3) | 0 | 0 | 0 | 0 | 2 (4.3) |
| 2 | 0 | 2 (4.3) | 0 | 0 | 0 | 2 (4.3) |
| 3 | 0 | 0 | 8 (17.0) | 1 (2.1) | 0 | 9 (19.1) |
| 4 | 0 | 0 | 1 (2.1) | 17 (36.2) | 0 | 18 (38.3) |
| 5 | 0 | 0 | 1 (2.1) | 6 (12.8) | 9 (19.1) | 16 (34.0) |
| Total | 2 (4.3) | 2 (4.3) | 10 (21.2) | 24 (51.1) | 9 (19.1) | 47 (100.0) |
Chi-Square test value: 62.4; P<0.001; Kappa value: 72.4. Grade 1–5, respectively, represented the diagnosis grading. 1: definite nonneoplasm; 2: possible nonneoplasm; 3: uncertain; 4: possible neoplasm; 5: definite neoplasm
Reviewing results of contrast-enhanced ultrasound between Observer I and Observer II
|
|
| |||||
|---|---|---|---|---|---|---|
|
| ||||||
|
|
|
|
|
|
| |
| 1 | 11 (23.4) | 0 | 0 | 0 | 0 | 11 (23.4) |
| 2 | 0 | 1 (2.1) | 1 (2.1) | 0 | 0 | 2 (4.3) |
| 3 | 0 | 0 | 2 (4.3) | 0 | 0 | 2 (4.3) |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 0 | 0 | 0 | 2 (4.3) | 30 (63.8) | 32 (68.0) |
| Total | 11 (23.4) | 1 (2.1) | 3 (6.4) | 2 (4.3) | 30 (63.8) | 47 (100.0) |
Chi-Square test value: 69.8; P<0.001; Kappa value: 87.4. Grade 1–5, respectively, represented the diagnosis grading. 1: Definite nonneoplasm; 2: Possible nonneoplasm; 3: uncertain; 4: possible neoplasm; 5: definite neoplasm